Island Pharmaceuticals commences key dengue fever drug trial in Australia
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA), has reached a milestone with the commencement of its Single Ascending Dose (SAD) study for ... Read More